GeneDx Holdings (WGSWW) Enterprise Value (2020 - 2026)

GeneDx Holdings (WGSWW) has 7 years of Enterprise Value data on file, last reported at -$170.7 million in Q1 2026.

• Enterprise Value for Q1 2026 came in at -$170.7 million, down 7.24% year-over-year; the trailing twelve-month figure through Mar 2026 was -$170.7 million (down 7.24% YoY), and the FY2025 annual result was -$171.3 million, down 21.32% from the prior year.
• Enterprise Value steadied at -$170.7 million in Q1 2026 per WGSWW's latest filing, from -$171.3 million in the prior quarter.
• Over five years, Enterprise Value peaked at -$106.9 million in Q2 2024 and troughed at -$315.0 million in Q1 2022.
• A 5-year average of -$164.6 million and a median of -$155.1 million in 2025 frame the typical range for Enterprise Value.
• On a YoY basis, Enterprise Value climbed as much as 69.06% in 2022 and fell as far as 973.92% in 2022.
• A 5-year view of Enterprise Value shows it stood at -$123.9 million in 2022, then retreated by 5.01% to -$130.1 million in 2023, then dropped by 8.48% to -$141.2 million in 2024, then fell by 21.32% to -$171.3 million in 2025, then climbed by 0.35% to -$170.7 million in 2026.
• Business Quant data shows WGSWW's Enterprise Value at -$170.7 million in Q1 2026, -$171.3 million in Q4 2025, and -$155.1 million in Q3 2025.